QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
Adam B. Murphy, MD, MBA, MSCI is Assistant Professor in the Department of Urology & Preventive Medicine at Northwestern University. He is Principal Investigator of a new study seeking to develop a genetic panel specifically to predict lethal prostate cancer…
A new drug approved by the Food and Drug Administration (FDA) is expected to immediately affect the treatment of some men with prostate cancer. In a large clinical trial, the drug, relugolix (Orgovyx), was shown to be more effective at…
Early in his career, Dr. Catalona cared for patients who were suffering and dying from metastatic prostate cancer, when disease was caught too late to be cured. After this experience, he was moved to dedicate his research to the early…
Even after apparently successful treatment, prostate cancer can unfortunately return, sometimes growing and spreading rapidly many years after the initial diagnosis. This occurs in prostate cancer when cancer cells leave the prostate early in the cancer’s development and hide in…
The FDA approved a new, more precise method of finding even the tiniest amounts of metastatic prostate cancer spread throughout in the body. The test, called a PSMA-PET scan, will make it easier to diagnose—and treat—metastatic prostate cancer sooner. The…
Previous research has reported on the impact of the U.S. Preventive Services Task Force recommendations against PSA screening for prostate cancer in 2008 for older men and in 2012 for all men. The rates of localized prostate cancer decreased, while…
Dr. Catalona, QUEST editor Betsy Haberl, and the URF Board wish to express our deepest gratitude to the photographers that have generously contributed images for use in QUEST. Thank you for sharing your talent and creativity with us! Alan Finesilver,…
by William J. Catalona, M.D., Medical Director of the URF My patients and Urological Research Foundation donors frequently ask about my research projects and professional educational activities. Contributions to the URF support my research, so I want to update QUEST…
MRI technology has not advanced enough for men with low-risk prostate cancer on active surveillance to forgo routine surveillance biopsies. While on active surveillance, men must have regular monitoring to make sure their disease has not progressed to the point…
Eating a healthy diet rich in fruits and vegetables has many benefits on overall health, and some research has shown that men who eat well have lower risks of developing diseases such as cancer. Research continues to explore if—and how—eating…
"*" indicates required fields
